DrugDashboards

Market view

clindamycin palmitate hydrochloride (pediatric)

4 marketed package NDCs · 2 active manufacturers

Most dispensed: CLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg/5mL · Solution · #1 bottle/carton / 100 ml in 1 bottle · CLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg/5mL · Solution · #1 bottle, plastic/carton / 100 ml in 1 bottle, plastic

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 23% over the past year, to $0.1302 per mL.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$0.2$0.4$0.6Nov 2013Sep 202602companies actively selling

Latest · Sep 2026 — typical price $0.1302 · middle half $0.1302–$0.1302 · full range $0.1302–$0.1302 · 4 products · 2 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per mLⓘSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for clindamycin palmitate hydrochloride (pediatric), newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Lincosamide Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Clindamycin palmitate hydrochloride (pediatric) in shortage right now?
No. FDA does not currently list Clindamycin palmitate hydrochloride (pediatric) in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Clindamycin palmitate hydrochloride (pediatric)?
2 companies have marketed Clindamycin palmitate hydrochloride (pediatric) in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Clindamycin palmitate hydrochloride (pediatric) cost?
The typical pharmacy pays about $0.1302 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.